These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 17596595)
1. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression. Privette LM; González ME; Ding L; Kleer CG; Petty EM Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595 [TBL] [Abstract][Full Text] [Related]
2. CHFR-associated early G2/M checkpoint defects in breast cancer cells. Erson AE; Petty EM Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445 [TBL] [Abstract][Full Text] [Related]
3. CHFR: a key checkpoint component implicated in a wide range of cancers. Sanbhnani S; Yeong FM Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584 [TBL] [Abstract][Full Text] [Related]
4. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells. Jiang G; Fang H; Shang X; Chen X; Cao F Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594 [TBL] [Abstract][Full Text] [Related]
5. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation. Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872 [TBL] [Abstract][Full Text] [Related]
6. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint. Privette LM; Weier JF; Nguyen HN; Yu X; Petty EM Neoplasia; 2008 Jul; 10(7):643-52. PubMed ID: 18592005 [TBL] [Abstract][Full Text] [Related]
7. CHFR suppression by hypermethylation sensitizes endometrial cancer cells to paclitaxel. Wang X; Yang Y; Xu C; Xiao L; Shen H; Zhang X; Li T; Li X Int J Gynecol Cancer; 2011 Aug; 21(6):996-1003. PubMed ID: 21792009 [TBL] [Abstract][Full Text] [Related]
8. Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. Corn PG; Summers MK; Fogt F; Virmani AK; Gazdar AF; Halazonetis TD; El-Deiry WS Carcinogenesis; 2003 Jan; 24(1):47-51. PubMed ID: 12538348 [TBL] [Abstract][Full Text] [Related]
9. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain. Fukuda T; Kondo Y; Nakagama H PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050 [TBL] [Abstract][Full Text] [Related]
10. Chfr is required for tumor suppression and Aurora A regulation. Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587 [TBL] [Abstract][Full Text] [Related]
11. Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Shibata Y; Haruki N; Kuwabara Y; Ishiguro H; Shinoda N; Sato A; Kimura M; Koyama H; Toyama T; Nishiwaki T; Kudo J; Terashita Y; Konishi S; Sugiura H; Fujii Y Carcinogenesis; 2002 Oct; 23(10):1695-9. PubMed ID: 12376479 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation. Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956 [TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of the CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma. Song A; Ye J; Zhang K; Yu H; Gao Y; Wang H; Sun L; Xing X; Yang K; Zhao M Leuk Res; 2015 May; 39(5):536-43. PubMed ID: 25798877 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of CHFR in human tumors. Toyota M; Sasaki Y; Satoh A; Ogi K; Kikuchi T; Suzuki H; Mita H; Tanaka N; Itoh F; Issa JP; Jair KW; Schuebel KE; Imai K; Tokino T Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7818-23. PubMed ID: 12810945 [TBL] [Abstract][Full Text] [Related]
15. CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer. Gao Y; Lou G; Zhang GM; Sun XW; Ma YY; Yang YM; Liu G Int J Biol Markers; 2009; 24(2):83-9. PubMed ID: 19634111 [TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia. Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487 [TBL] [Abstract][Full Text] [Related]
17. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer. Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017 [TBL] [Abstract][Full Text] [Related]
18. CHFR functions as a ubiquitin ligase for HLTF to regulate its stability and functions. Kim JM; Cho EN; Kwon YE; Bae SJ; Kim M; Seol JH Biochem Biophys Res Commun; 2010 May; 395(4):515-20. PubMed ID: 20388495 [TBL] [Abstract][Full Text] [Related]
19. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer. Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269 [TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors. Ogi K; Toyota M; Mita H; Satoh A; Kashima L; Sasaki Y; Suzuki H; Akino K; Nishikawa N; Noguchi M; Shinomura Y; Imai K; Hiratsuka H; Tokino T Cancer Biol Ther; 2005 Jul; 4(7):773-80. PubMed ID: 16123600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]